These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29402680)

  • 1. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
    Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J
    Drug Alcohol Depend; 2018 Mar; 184():57-63. PubMed ID: 29402680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
    Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
    Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal.
    Moore KE; Oberleitner L; Smith KMZ; Maurer K; McKee SA
    J Addict Med; 2018; 12(2):156-162. PubMed ID: 29341974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of methadone initiation prior to release from incarceration.
    McKenzie M; Zaller N; Dickman SL; Green TC; Parihk A; Friedmann PD; Rich JD
    Subst Abus; 2012; 33(1):19-29. PubMed ID: 22263710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia.
    Ahmad A; Bromberg DJ; Shrestha R; Salleh NM; Bazazi AR; Kamarulzaman A; Shenoi S; Altice FL
    Int J Drug Policy; 2024 Apr; 126():104369. PubMed ID: 38484531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.
    Pourtaher E; Gelberg KH; Fallico M; Ellendon N; Li S
    J Subst Use Addict Treat; 2024 Jun; 161():209248. PubMed ID: 38081540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-Based Methadone Maintenance in a Large Detention Center is Associated with Decreases in Inmate Recidivism.
    Westerberg VS; McCrady BS; Owens M; Guerin P
    J Subst Abuse Treat; 2016 Nov; 70():1-6. PubMed ID: 27692182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.
    Mukherjee TI; Wickersham JA; Desai MM; Pillai V; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2016 Jul; 164():120-127. PubMed ID: 27207155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incarcerated intravenous heroin users: predictors of post-release utilization of methadone maintenance treatment.
    Lin HC; Wang PW; Yang YH; Tsai JJ; Yen CF
    J Addict Dis; 2016; 35(2):109-18. PubMed ID: 26670167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of a large jail-based methadone maintenance treatment continuation program in New Mexico.
    Horn BP; Li X; McCrady B; Guerin P; French MT
    J Subst Abuse Treat; 2020 Aug; 115():108042. PubMed ID: 32600623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting.
    Brinkley-Rubinstein L; Peterson M; Clarke J; Macmadu A; Truong A; Pognon K; Parker M; Marshall BDL; Green T; Martin R; Stein L; Rich JD
    Drug Alcohol Depend; 2019 Dec; 205():107514. PubMed ID: 31614328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-incarceration outcomes for individuals who continued methadone treatment while in Connecticut jails, 2014-2018.
    Haas A; Viera A; Doernberg M; Barbour R; Tong G; Grau LE; Heimer R
    Drug Alcohol Depend; 2021 Oct; 227():108937. PubMed ID: 34371235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-release treatment uptake among participants of the Rhode Island Department of Corrections comprehensive medication assisted treatment program.
    Martin RA; Gresko SA; Brinkley-Rubinstein L; Stein LAR; Clarke JG
    Prev Med; 2019 Nov; 128():105766. PubMed ID: 31279770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
    Larney S; Zador D; Sindicich N; Dolan K
    Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users.
    Mitchell SG; Kelly SM; Brown BS; Reisinger HS; Peterson JA; Ruhf A; Agar MH; Schwartz RP
    J Psychoactive Drugs; 2009 Jun; 41(2):145-52. PubMed ID: 19705676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.
    Bazazi AR; Wickersham JA; Wegman MP; Culbert GJ; Pillai V; Shrestha R; Al-Darraji H; Copenhaver MM; Kamarulzaman A; Altice FL
    Contemp Clin Trials; 2017 Aug; 59():1-12. PubMed ID: 28479216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.
    Lo A; Kerr T; Hayashi K; Milloy MJ; Nosova E; Liu Y; Fairbairn N
    J Subst Abuse Treat; 2018 Nov; 94():41-46. PubMed ID: 30243416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.